The Chemours Company (CC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
9 Sep, 2026Business overview and segment performance
Operates three main segments: Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), each with global reach and specialized product portfolios.
TSS focuses on low-GWP refrigerants (Opteon™), legacy Freon™, and foam/propellant products, with strong exposure to regulatory-driven growth in HVAC, data centers, and automotive markets.
TT is a global leader in TiO2 production, emphasizing cost leadership and reliability, with a mid-cycle EBITDA floor target of $400M.
APM targets high-growth sectors like semiconductors, data centers, and advanced electronics, with over 40% of Performance Solutions sales in these markets as of 2Q26.
Geographic sales mix: North America 47%, EMEA 20%, Asia Pacific 20%, Latin America 13%.
Strategic progress and growth initiatives
Pathway to Thrive strategy centers on operational excellence, targeted growth investments, portfolio optimization, and resolving legacy liabilities.
Achieved over $250M in cost reductions from 2024 to 2027, with Lean principles embedded across operations.
Advanced R&D in next-generation refrigerants and two-phase cooling for AI/data center infrastructure, with annual R&D spend of $20–25M.
Expanded presence in high-value end markets, especially data centers and semiconductors, with TSS and APM products supporting next-gen infrastructure.
Progressed portfolio management through asset sales, site exits, and focus on higher-return businesses.
Regulatory and market trends
Regulatory phase-downs of HFCs in the US (AIM Act) and EU (F-Gas) are accelerating adoption of low-GWP Opteon™ refrigerants.
TSS is positioned for GDP+ growth and 30%+ margins, with IP protection extending into the late 2030s.
Data center chiller market offers double-digit growth, with new product launches (R-515B, Opteon™ ZE) expanding addressable opportunities.
Aftermarket growth in refrigerants expected as installed base of new units expands, despite short-term macro headwinds.
Latest events from The Chemours Company
- Adjusted EBITDA was $247M on flat sales, with improved cash flow and lower net loss year-over-year.CC
Q2 2026 - Virtual annual meeting set for April 2026 with key votes on directors, pay, and auditor.CC
Proxy filing - TSS strength drove $1.4B sales and $169M EBITDA, despite wider net loss and TT/APM declines.CC
Q1 2026 - 2025 net sales reached $5.8B, driven by Opteon growth, cost savings, and asset optimization.CC
Investor presentation - Board refreshment, strategic execution, and ESG progress headline this year's proxy.CC
Proxy Filing - TSS Opteon™ growth and strong cash flow drive 2026 outlook amid TT/APM headwinds.CC
Q4 2025 - Q3 2024 featured strong Opteon™ growth, TT margin gains, and ongoing cost reduction initiatives.CC
Investor presentation - Q2 2024 net sales fell 6% to $1.54B; Opteon and TT volumes offset pricing headwinds.CC
Q2 2024 - Chemours targets growth in refrigerants and data center cooling while managing PFAS liabilities.CC
Gabelli Funds' 16th Annual Specialty Chemicals Symposium